Merck Global Health Innovation Fund — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
TransVoyantDec 2022
Alexandria, US
Dennis Groseclose(Executive Officer, Director)Shariar Shahidi(Executive Officer)Dawn Morat(Executive Officer)James Clautice(Executive Officer)
BoardPatrick McPherson(Director)Joseph Volpe(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.